Daring to Fail Forward: The Mindset Catalyzing Healthcare Breakthroughs – Christian Howell : 34

The Emerging Biotech Leader
The Emerging Biotech Leader
Daring to Fail Forward: The Mindset Catalyzing Healthcare Breakthroughs - Christian Howell : 34
Loading
/

This episode features an interview with Christian Howell, Chief Commercial Officer at Cognito Therapeutics, a biotech company pioneering a neurotechnology approach to treat Alzheimer's disease. Christian draws on his diverse background spanning the military, medical device giant Medtronic, and now the biotech industry.

The conversation covers Cognito's evidence generation strategy to demonstrate the value of their non-invasive neural stimulation therapy. As Christian states, "It's critical to bring all the key players to the table early and be fully transparent about your data - that's how you build trust and alignment around value."

Key takeaways include:

  • The importance of cross-sector partnerships and stakeholder engagement from day one
  • Fostering a culture of innovation through mission-driven leadership
  • Promoting employee accountability to take smart risks
  • Learning quickly from failures versus avoiding them

With experience implementing value-based healthcare models at Medtronic, Christian also shares unique perspectives on driving innovation while developing novel therapies.

Learn from Christian’s approach spanning evidence generation, collaborative value demonstration, and creating an environment primed for breakthrough thinking.  Listen in and get inspired!

Are you leading a biotech and would like to share your experience with our podcast audience? We'd love to hear from you! Please reach out to us.

More Episodes Like This

30-08-2024

Patients as Partners: A Winning Strategy for Drug Development – Laurie Smaldone-Alsup: 37

Early collaboration with patient advocacy groups can transform the development process, providing invaluable insights that shape everything from clinical trial design to regulatory strategies.
16-08-2024

Rare Diseases, Real Lives: Bridging Patient Needs and Drug Development – Dr. Edward M. Kaye : 36

While drug approval matters, the real aim is ensuring patients can access and use the treatments. This involves working with various healthcare systems and considering patient costs.
29-07-2024

Real-World Evidence and Putting Patients at the Center of Drug Development – Dr. Chantal van Gils : 35

Real-world evidence data is critical not just for regulatory approvals, but for convincing payers and patients of a product's value in the real world.
27-06-2024

Avoiding Common Pitfalls in the Biotech Development Process – Dr. Thomas Lönngren : 33

Regulatory approval alone is insufficient for commercial success in today's landscape. Companies must also consider health technology assessment (HTA) and payer requirements, which can be more stringent than regulatory approval.
17-06-2024

Redefining Roles: From Medical Practice to Biotech Ventures : 32

Biotech leadership thrives on diverse experiences and willingness to face new challenges. Effective leaders cultivate collaborative teams, promote adaptability, and balance innovation with financial constraints as they grow their companies.
31-05-2024

Balancing Current Needs and Long-Term Goals in Biotech : 31

Building evolving biotech organizations requires balancing short-term demands with long-term objectives. Leveraging leaders as cross-functional connectors and prioritizing self-awareness and humility are paramount for driving organizational success.

LET’S TALK

You don't have to go it alone! Our experienced team has been there before, and we're ready to guide you through the unknown. Share your challenges with us, and together, we'll create a plan to efficiently reach your milestones and turn your vision into reality.

Building Better Biotechs.

This field is for validation purposes and should be left unchanged.